1. Methylphenidate-Induced Nocturnal Bruxism Alleviated by Adjunctive Clonidine.
- Author
-
Naguy A, Elsori D, and Alamiri B
- Subjects
- Child, Drug Therapy, Combination, Female, Humans, Jordan, Analgesics therapeutic use, Attention Deficit Disorder with Hyperactivity complications, Attention Deficit Disorder with Hyperactivity drug therapy, Central Nervous System Stimulants adverse effects, Central Nervous System Stimulants agonists, Central Nervous System Stimulants therapeutic use, Clonidine therapeutic use, Methylphenidate adverse effects, Methylphenidate therapeutic use, Sleep Bruxism etiology
- Abstract
Stimulants-related bruxism has been previously reported; both diurnal and nocturnal. Here, authors report on a case of methylphenidate (MPH)-treated attention-deficit/hyperactivity disorder that developed nocturnal bruxism and failed multiple pharmacologic trials. Add-on clonidine has successfully helped with bruxisms while augmenting MPH response. This was achieved with great tolerability. This remains a viable option to deploy in such unusual clinical scenarios.
- Published
- 2019
- Full Text
- View/download PDF